Corcept Therapeutics Incorporated (CORT) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Corcept Therapeutics Incorporated (CORT)

CORT 74.20

+1.0%

Nov 3 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: mopgcw who wrote (3)	6/23/2004 9:07:45 PM
From: mopgcw	Read Replies (1) of 32

Corcept Therapeutics Raises $54 Million in IPO (Correct) 2004-04-27 07:18 (New York) (Corrects description of what disease the company is developing in first paragraph of story published April 14.) By Brett Cole April 14 (Bloomberg) -- Corcept Therapeutics Inc., which is developing drugs to treat major psychotic depression, raised $54 million in an initial public offering and will use the proceeds to conduct clinical drug trials. Corcept, based in Menlo Park, California, sold 4.5 million shares for $12 each, down from an earlier price range of between $15 and $17 a share, according to a Securities and Exchange Commission filing. Thomas Weisel Partners LLC managed the IPO, sharing fees of $3.8 million with Piper Jaffray Cos. and Legg Mason Wood Walker Inc. Corcept, which was formed in 1998 and said its drugs are in a developmental stage, had a net loss of $9.8 million in 2003 compared with a net loss of $18.5 million in 2002. It expects its losses to ``increase for the foreseeable future,'' the SEC filing said. The stock will trade on the Nasdaq Stock Market under the symbol ``CORT.''

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next